Paradigm Biopharmaceuticals (ASX:PAR) FCF Yield % : -82.80 (As of Apr. 27, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Paradigm Biopharmaceuticals FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Paradigm Biopharmaceuticals's Trailing 12-Month Free Cash Flow is A$-78.46 Mil, and Market Cap is A$94.76 Mil. Therefore, Paradigm Biopharmaceuticals's FCF Yield % for today is -82.80%.

The historical rank and industry rank for Paradigm Biopharmaceuticals's FCF Yield % or its related term are showing as below:

ASX:PAR' s FCF Yield % Range Over the Past 10 Years
Min: -82.8 Med: 0 Max: 0
Current: -82.8

ASX:PAR's FCF Yield % is ranked worse than
81.81% of 1550 companies
in the Biotechnology industry
Industry Median: -15.535 vs ASX:PAR: -82.80

Paradigm Biopharmaceuticals's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

Paradigm Biopharmaceuticals FCF Yield % Historical Data

The historical data trend for Paradigm Biopharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Paradigm Biopharmaceuticals FCF Yield % Chart

Paradigm Biopharmaceuticals Annual Data

Trend

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

FCF Yield %

Get a 7-Day Free Trial

-2.37

-1.44

-7.24

-14.34

-16.20

Paradigm Biopharmaceuticals Semi-Annual Data
	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
FCF Yield %	Get a 7-Day Free Trial												-7.64	-13.79	-8.95	-19.67	-68.31

Competitive Comparison of Paradigm Biopharmaceuticals's FCF Yield %

For the Biotechnology subindustry, Paradigm Biopharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Paradigm Biopharmaceuticals's FCF Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Paradigm Biopharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Paradigm Biopharmaceuticals's FCF Yield % falls into.

Paradigm Biopharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Paradigm Biopharmaceuticals's FCF Yield % for the fiscal year that ended in Jun. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-45.186	/	278.938477828
	=	-16.20%

Paradigm Biopharmaceuticals's annualized FCF Yield % for the quarter that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-51.023	*	2	/	149.3858
	=	-68.31%

Paradigm Biopharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Paradigm Biopharmaceuticals FCF Yield % Related Terms

Thank you for viewing the detailed overview of Paradigm Biopharmaceuticals's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Paradigm Biopharmaceuticals (ASX:PAR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Paradigm Biopharmaceuticals Ltd (ASX:PAR) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

PBIGF:USA

Address

500 Collins Street, Level 15, Melbourne, VIC, AUS, 3000

Website

https://www.paradigmbiopharma.com

Paradigm Biopharmaceuticals Ltd is a biopharmaceutical company that engages in the research and development of therapeutic products for human use in Australia. The firm is engaged in drug repurposing, pentosan polysulphate sodium (PPS) for the lead clinical indication of bone marrow edema, Alphavirus - Ross River virus (RRV) and Chikungunya virus (CHIKV), Mucopolysaccharidosis, and allergic respiratory conditions, including allergic rhinitis (AR) and chronic obstructive pulmonary disease (COPD).